摘要
目的探讨部分脾栓塞术(PSE)的临床应用。方法采用PSE治疗肝癌伴脾亢(HCC-HS)86例,其它继发性脾亢(SHS)26例,原发性血小板减少性紫癜(ITP)5例,其中20例2次以上PSE。结果平均栓塞范围HCC-HS组为36%,SHS组为60%,ITP组为74%;临床有效率分别为84.8%、88.5%、100%。HCC-HS组因单次栓塞范围较小,约20.9%(18/86)病人需行再次栓塞。全部病例均未发生严重并发症。结论PSE是安全有效的,可作为外科脾切除的替代疗法。HCC-HS组为了减轻术后并发症PSE可分次进行。
Objective：To probe the chinical application of partial splenic embolization （PSE）. Methods：86 cases of hepatocellular carcionma with hypersplenism （HCC-HS）, 26 cases of secondary hypersplenism（SHS） and 5 cases of idiopathic thrombocytopenic purpura（ITP）have been treated by PSE. Results ：The average extents of HCC-HS,SHS and ITP emboliztion were 36% ,60% ,74% respectively,and the clinical effective rates were 84.8 %, 88.5 %, 100% respectively,and the clinical effective rates were 84. 8% ,88.5% ,100% respectively. Because of the extent of once embolization was too small in the HCC-HS group ,20.9%（18/86） patients had to he treated again by PSE. No severe complication occurred in all cases. Conclusion：PSE is a safe and effective therapy,and it could take the place of surgical splenecomy under certain condition as indicated. To decrease complication of postoperative HCC-HS patients, the PSE should he carried out twice or more.
出处
《哈尔滨医药》
2006年第3期2-4,共3页
Harbin Medical Journal
关键词
部分脾栓塞术
脾功能亢进
原发性血小板紫癜
Splenic emholization partial
Hypersplenism
Idiopathic thromhocytopenic purpura
